UFSP2 inhibitor compound-8 | UFSP2 inhibitor

Chemical Structure : UFSP2 inhibitor compound-8

CAS No.: 850188-43-1

UFSP2 inhibitor compound-8 (UFSP2 inhibitor)

Catalog No.: PC-20117Not For Human Use, Lab Use Only.

UFSP2 inhibitor compound-8 is a small molecule covalent inhibitor of UFSP2 (UFM1 Specific Peptidase 2), binds to Cys294 of UFSP2, promotes the protein modification by Ubiquitin-fold modifier 1 (UFM1) (UFMylation) of PD-L1 and destabilizes PD-L1.

Packing	Price	Stock
5 mg	$258	In stock
10 mg	$398	In stock
25 mg	$588	In stock
50 mg		Get quote
100 mg		Get quote

Get Quotation Now

* Please select Quantity before adding items.

or Bulk Inquiry

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Biological Activity

UFSP2 inhibitor compound-8 is a small molecule covalent inhibitor of UFSP2 (UFM1 Specific Peptidase 2), binds to Cys294 of UFSP2, promotes the protein modification by Ubiquitin-fold modifier 1 (UFM1) (UFMylation) of PD-L1 and destabilizes PD-L1.

Compound-8 (5 μg/mL) could significantly and consistently improve the global UFMylation activity in both MDA-MB-231 and MC38 cells.

Compound-8 (5-15 μg/mL)decreased the expression of PD-L1 without affecting the UFSP2 protein levels.

Compound-8 dose dependently enhanced the global UFMylation proteins while decreasing the expression of PD-L1.

Compound-8 imparts tumor immune evasion in vivo, exhibits better antitumor effect with no appreciable body weight loss when combined with PD-1 blockade.

UFSP2 is the primary "de-UFMylation" enzyme in human cells, UFSP2 acts as a de-UFMylation enzyme for PD-L1 through direct physical interaction.

Physicochemical Properties

M.Wt	209.64
Formula	C6H8ClNO3S
Appearance	Solid
CAS No.
Storage	Solide Powder -20°C 12 Months; 4°C 6 Months	In Solvent -80°C 6 Months; -20°C 6 Months
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	2-chloro-N-(1,1-dioxido-2,3-dihydrothiophen-3-yl)acetamide

References

1. Zhou J, et al. Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2215732120.